COc1ccc2c3c(n(Cc4ccccc4)c(=O)c2c1)-c1cc(OC)c(OC)cc1C3C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?